Subsense: Funding, Investors & Team (Oct 2026)
Subsense develops non-surgical brain-computer interface (BCI) technologies that link neural activity with external systems using engineered nanoparticles and integrated hardware and software. The company focuses on bidirectional interfaces designed to record and stimulate brain signals without surgical implants, targeting applications in neurological treatment, human-machine interaction and neural diagnostics. Its offerings include nanoparticle systems, signal processing platforms and research collaborations with academic institutions to advance non-invasive neural connectivity. Subsense also works on tools and algorithms to interpret brain activity for potential therapeutic and assistive uses in neurological conditions.
Subsense has raised $10.0M across 1 funding round on record, the most recent a Seed of $10.0M announced in Dec 2025.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Subsense Company Profile and Key Stats
Latest funding round on record: Dec 2025.
Subsense Funding Rounds
Subsense Founders and Leadership Team
Contact details for the Subsense team: 1 of 1 has an email address on file.
Start 14-day free trial →Subsense Funding Compared to Other Biotechnology Startups
Subsense's latest round of $10.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Subsense in Biotechnology and Covina
Companies Similar to Subsense
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Subsense Funding FAQs
What does Subsense do?
Subsense develops non-surgical brain-computer interface (BCI) technologies that link neural activity with external systems using engineered nanoparticles and integrated hardware and software. The company focuses on bidirectional interfaces designed to record and stimulate brain signals without surgical implants, targeting applications in neurological treatment, human-machine interaction and neural diagnostics. Its offerings include nanoparticle systems, signal processing platforms and research collaborations with academic institutions to advance non-invasive neural connectivity. Subsense also works on tools and algorithms to interpret brain activity for potential therapeutic and assistive uses in neurological conditions.
How much funding has Subsense raised?
Subsense has raised $10.0M across 1 round on record. The most recent is a Seed of $10.0M announced in Dec 2025.
When did Subsense last raise funding?
Subsense's most recent funding round on record is a Seed of $10.0M, announced in Dec 2025.
Who founded Subsense?
FundedIQ lists Tetiana Aleksandrova (Founder) at Subsense.
Where is Subsense headquartered?
Subsense is based in Covina, California, United States.
How many employees does Subsense have?
Subsense is in the 11-50 employee band.
How does Subsense's funding compare to other Biotechnology startups?
Subsense's latest round of $10.0M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Subsense Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Subsense is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.